drugset / Trial / NCT03403569

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

NCT03403569 ↗

Phase 3 Completed 353 enrolled Peking Union Medical College Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The traditional Chinese herbal medicine Triptolide Wilfordii has displayed remarkable effect on the treatment of autoimmune diseases such as rheumatoid arthritis. Now that immunosuppression therapy has recently become a new strategy for HIV infection, it's reasonable to expect the anti-inflammatory effect of Triptolide Wilfordii in HIV infected patients. So we designed a randomized, double-blinded, placebo-controlled study to explore the efficacy and safety of Triptolide Wilfordii in new-onset HIV infection.

Timeline

Start
2018-09-01
Primary completion
2021-06-30
Completion
2021-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptolide Wilfordii Traditional medicine (herbal / TCM) 20 mg Oral